Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,8813,900 of 20,252 grants

Completed OTHER RESEARCH-RELATED
The Role of Platelets in Establishing the Lung Pre-Metastatic Niche in Breast Cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

PROJECT SUMMARY Tumor metastasis remains responsible for >65% of cancer-associated mortality and nearly all breast cancer deaths. Given the difficulties in treating metastatic d...

$1.78M
USD
Active NON-SBIR/STTR RPGS
Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Millions of women worldwide have undergone mastectomy and breast reconstruction procedures. Simple (also called total) mastectomy, the most common mastecto...

$7.51M
USD
Active NON-SBIR/STTR RPGS
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2028

Abstract Development of immune-related adverse effects (irAEs) is one of the significant challenges of current approved cancer therapy with immune checkpoint inhibitors (ICIs) of t...

$6.31M
USD
Active NON-SBIR/STTR RPGS
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY Compared to Whites, African American/Blacks (AA/B) have a substantially higher (40-50%) colorectal cancer (CRC) mortality rate that is a function of both higher inc...

$5.97M
USD
Active NON-SBIR/STTR RPGS
The abuse liability, topography and toxicology of ice flavors and non-menthol synthetic cooling agents in e-cigarette products
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY Recently, synthetic cooling agents, WS-3 (N-ethyl-p-menthane-3-carboxamide) and WS-23 (2-isopropyl-N,2,3 trimethylbutyramide), that solely impart a cooling sensatio...

$7.13M
USD
Active RESEARCH CENTERS
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

$10.59M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

Active RESEARCH CENTERS
Project 1
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

Active RESEARCH CENTERS
Project 2
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

Active RESEARCH CENTERS
Shared Resources Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

Active RESEARCH CENTERS
Developmental Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Braz...

Completed NON-SBIR/STTR RPGS
Dissecting Neuro-Immune Interactions in Cancer
NATIONAL CANCER INSTITUTE University of Basel Switzerland 2023 – 2025

PROJECT SUMMARY/ABSTRACT: Cancer is highly adept at exploiting normal physiological functions to support its growth. One important component of tissue physiology is neurons which w...

$1.08M
USD
Active NON-SBIR/STTR RPGS
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is particularly resistant to therapy and typically presents as metastatic disease. Characterized by hypoxia, dense stroma, and meta...

$4.43M
USD
Completed NON-SBIR/STTR RPGS
Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY Older adults with cancer (OACs) comprise a large and growing proportion of cancer patients and survivors. Many OACs have unmet behavioral health needs with signific...

$2.06M
USD
Completed NON-SBIR/STTR RPGS
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2025

PROJECT SUMMARY: Radiotherapy can be a highly effective treatment for many types of cancers. A major impediment to achieving its full curative promise is the current delivery proce...

$4.65M
USD
Active NON-SBIR/STTR RPGS
Microfluidic technology to isolate tumoricidal T-cells from peripheral blood
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2026

PROJECT SUMMARY Adoptive cell transfer (ACT) using ex vivo expanded anti-tumor T-cells has garnered significant interest due to successes in treating melanoma and other cancers. Th...

$2.14M
USD
Active OTHER RESEARCH-RELATED
Using natural killer cells to prevent breast cancer metastases
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Project Summary/Abstract Most of breast cancer related mortality is related to metastatic disease. While NK cells play an essential role in the control of metastatic breast cancer...

$2.55M
USD
Completed NON-SBIR/STTR RPGS
OR2H1 is an effective target for CAR T cells in human epithelial tumors
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2025

ABSTRACT Identifying accessible tumor antigens that are not expressed in vital organs would allow genetic engineering of CAR T cells to avoid dysfunction at tumor beds. We have ide...

$2.14M
USD
Completed OTHER RESEARCH-RELATED
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2025

PROJECT SUMMARY The decreased quality of life and increased morbidity due to oncological drugs such as Tyrosine Kinase Inhibitors (TKIs) is a serious and growing general health pro...

$1.54M
USD
Active NON-SBIR/STTR RPGS
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Lineage plasticity has emerged as an important mechanism of treatment resistance in prostate cancer that results into multiple different tumor states. Recent classifications effort...

$5.22M
USD